scispace - formally typeset
W

Werner Hacke

Researcher at Heidelberg University

Publications -  688
Citations -  93115

Werner Hacke is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 123, co-authored 656 publications receiving 84593 citations. Previous affiliations of Werner Hacke include University Hospital Heidelberg & Steklov Mathematical Institute.

Papers
More filters
Journal ArticleDOI

Acute ischaemic stroke: revascularizing therapy. Stroke Council of the American Heart Association

TL;DR: Since treating ineligible patients is associated with an unacceptable risk of intracranial bleeding complications and death, intravenous thrombolysis should only be performed at selected centres in selected patients.
Journal ArticleDOI

Akute klinische Schlaganfallbehandlung

TL;DR: Management of the acute phase of stroke is the target of this article and significant sustained neurological improvement has been demonstrated when thrombolytic treatment, mainly with recombined tissue plasminogen activator (rtPA) is initiated within the first hours of stroke onset.
Journal ArticleDOI

Early termination of THRILL, a prospective study of mechanical thrombectomy in patients with acute ischemic stroke ineligible for i.v. thrombolysis.

TL;DR: The primary objective of the THRILL study was to test the efficacy of thrombectomy with stent retrievers in AIS patients with large intracranial vessel occlusion in the anterior circulation who are not eligible for intravenous recombinant tissue plasminogen activator (i.v.-tPA) treatment.
Journal ArticleDOI

Therapiemöglichkeiten bei schweren, intensivpflichtigen Sinus- und Venenthrombosen

TL;DR: In this paper, the authors present an interdisziplinares Therapiekonzept dar, das anhand von 5 Fallen vorgestellt werden soll.
Journal Article

Bolus Injection of MR Contrast Agents: Hemodynamic Effects Evaluated by Intracerebral Laser Doppler Flowmetry in Rats

TL;DR: It is concluded that gadopentetate dimeglumine is well suited for cerebral MR perfusion imaging without inherent influence on cerebral blood flow and that the same is probably true for polylysine-Gd-DTPA and SPIO.